Display Settings:


Send to:

Choose Destination
J Gastrointest Oncol. 2013 Jun;4(2):193-7. doi: 10.3978/j.issn.2078-6891.2013.024.

Can only chemoradiotherapy and chemotherapy treatment be applied to patients with rectal cancer who could not be operated?

Author information

  • 1Dokuz Eylül University, Medical Faculty, Department of Internal Diseases, Divison of Medical Oncology, İnciraltı, 35340, Izmir, Turkey.



This study is aimed to evaluate patients with non-metastatic rectal cancer who could not be operated due to any reason and were treated with chemoradiotherapy alone or chemotherapy following chemoradiotherapy.


Patients with locally advanced non-metastatic rectal cancer, who were treated and followed-up were evaluated.


Totally 263 patients with stage II and III rectal cancer were evaluated. It was determined that 14 (5.2%) of the patients with locally advanced stages received chemoradiotherapy alone or chemotherapy following chemoradiotherapy, and they were followed-up instead of undergoing operation. The baseline assessments revealed that 8 (57.1%) patients had clinical stage II, and 6 (42.9%) patients had clinical stage III diseases. Recurrence was detected in 3 (21.4%) patients. 6 (42.9%) patients died, and death due to rectal cancer progression was detected in 2 (14.3%) patients. Median progression-free survival was 25 months (8 to 68 months), median overall survival was 35 months (12 to 68 months), overall survival rates in 1, 3 and 5 years were 92.9%, 69.8% and 52.4%, respectively.


Chemoradiotherapy alone or subsequent chemotherapy after chemoradiotherapy may be suitable for patients with non-metastatic locally advanced rectal cancer who could not be operated due to any reason.


Locally advanced rectal cancer; chemoradiotherapy; chemotherapy

Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Pioneer Bioscience Publishing Company Icon for PubMed Central
    Loading ...
    Write to the Help Desk